Hagens Berman Alerts Evolent Health (EVH) Investors to Class Action, Encourages Investors Who Lost $100,000+ to Contact the Firm

08/13/2019

San Francisco - Hagens Berman Sobol Shapiro LLP alerts investors in Evolent Health, Inc. (NYSE: EVH) to the securities class action, Plymouth County Retirement System v. Evolent Health, Inc. et al., No. 1:19-cv-01031 pending in the U.S. District Court for the Eastern District of Virginia.

If you invested in Evolent Health between March 3, 2017 and May 28, 2019 (the “Class Period”) and suffered losses you do not need to sign up to be included in the putative class of investors.

If you suffered significant losses (in excess of $100,000) you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.  The Lead Plaintiff deadline is October 7, 2019.  Contact Hagens Berman immediately to learn more about this case and being a lead plaintiff:

https://www.hbsslaw.com/investor-fraud/EVH

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

EVH@hbsslaw.com.

According to the Complaint, Defendants misled investors by misrepresenting and concealing (1) Evolent’s business model was designed to inflate its revenue by extracting enormous fees at the expense of its operating partners such as Passport and, therefore, did not align its interests with those of its partners, (2) the model became increasingly unsustainable after Kentucky cut its reimbursement rates,
(3) Evolent was draining Passport of functions, employees and money, further undermining Passport’s solvency, and (4) Passport was trying to sell itself for several months to avoid liquidation.

On May 29, 2019, Evolent shocked investors when it unexpectedly announced it was buying a controlling interest in Passport.  This news drove the price of Evolent shares sharply lower.

“We’re focused on Defendants’ statements about having no plans to buy Passport or any other health plans for the foreseeable future may have misled investors,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Evolent Health should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email EVH@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000


Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.

Back to all cases